RJA
COV

Raymond James & Associates’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Raymond James & Associates’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-183,294
Closed -$18.7M – 2463
2014
Q4 		$18.7M Sell
183,294
-3,765
-2% -$361K 0.09% 240
2014
Q3 		$16.2M Sell
187,059
-58,177
-24% -$5.15M 0.09% 231
2014
Q2 		$22.1M Sell
245,236
-24,698
-9% -$1.85M 0.14% 159
2014
Q1 		$19.9M Buy
269,934
+36,443
+16% +$2.54M 0.14% 159
2013
Q4 		$15.9M Buy
233,491
+37,193
+19% +$2.42M 0.12% 184
2013
Q3 		$12M Buy
196,298
+7,613
+4% +$465K 0.1% 207
2013
Q2 		$10.5M Buy
+188,685
New +$10.9M 0.1% 224

Raymond James & Associates's COV Position: Q1 2015 in Review

Raymond James & Associates sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 183,294 shares — an estimated $18.7M sold.

Raymond James & Associates first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $22.1M in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Raymond James & Associates reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Raymond James & Associates sold 183,294 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $18.7M.
  • Raymond James & Associates first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Raymond James & Associates's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $22.1M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Raymond James & Associates's 13F filing for Q1 2015, filed 28 Apr 2015.